Sort by
Refine Your Search
-
Listed
-
Category
-
Employer
- KINGS COLLEGE LONDON
- Cranfield University
- The University of Manchester
- University of Birmingham
- University of Birmingham;
- ;
- AALTO UNIVERSITY
- Bangor University
- King's College London
- University of Bradford;
- University of Cambridge
- University of Hertfordshire
- University of Newcastle
- University of Plymouth;
- 4 more »
- « less
-
Field
-
perform experiments that interrogate the molecular and cellular mechanisms of novel anti-cancer drugs, employing cellular, biochemical and molecular biological approaches. You will publish your research in
-
scattering with computer modelling such as molecular dynamics simulations and AI-assisted data mining. The new technical capabilities will help bridge the current gap in biocide development, i.e., to link
-
in genotyping, molecular biology and Drosophila work. CDN has close partnership with the Medical Research Council (MRC) and CDN researchers, together with clinical researchers from King’s, make up
-
have or expect to obtain a first or upper second-class degree in a relevant subject from a UK university, or equivalent standard abroad. Prior research experience, for instance in molecular biology
-
pigmented and non-pigmented silicone elastomers developed within AMFaces. The successful candidate will simulate aging through cellular senescence and ECM modifications, incorporate immune cells to reflect
-
& Neuroscience and is located at Guy’s campus. Researchers have access to support facilities in genotyping, molecular biology and Drosophila work. CDN has close partnership with the Medical Research Council (MRC
-
the University or Research Centre where the research will be undertaken. Click here for a copy of the job description. Application Information The three documents needed for upload are a copy of your current
-
(ToF-PET) provides critical functional and molecular insights to improve cancer staging but is currently limited by detector timing resolution and sensitivity. Metascintillators, an emerging family of
-
Tomography (ToF-PET) offers vital functional and molecular insights for improved cancer staging, its current capabilities are often limited by the timing resolution and sensitivity of existing detector
-
device nanofabrication and clean room processing of 2D materials (required). Skill sets of handling low-temperature and ultra-high vacuum systems, such as molecular beam epitaxy (MBE) or STM experience